|
300107
By:
Pulak Ghosh
|
8:55 AM 08/14/2002
|
|
Some Methodological and Computational Aspects of Bioequivalence
|
|
300522
By:
Scott D. Patterson
|
8:35 AM 08/13/2002
|
|
Statistical Aspects of Bioequivalence in the Pharmaceutical Industry
|
|
300671
By:
Tie-Hua Ng
|
11:35 AM 08/13/2002
|
|
Iterative Chi-Square Test for Equivalence of Multiple Treatment Groups
|
|
300688
By:
Brian L. Wiens
|
10:55 AM 08/13/2002
|
|
Equivalence of Multiple Treatments with a Control: Design and Analysis Issues
|
|
300741
By:
Boris Iglewicz
|
11:15 AM 08/13/2002
|
|
Multi-Treatment Equivalence Trials: Design and Analysis Considerations
|
|
300809
By:
Hui Quan
|
2:35 PM 08/11/2002
|
|
Treatment by stratum interaction test for equivalence trials
|
|
300834
By:
Michael Lu
|
5:05 PM 08/11/2002
|
|
Defining Equivalence Margin in IVD Equivalence Studies
|
|
300947
By:
Yonghee Lee
|
8:50 AM 08/13/2002
|
|
Statistical Test for Population Bioequivalence
|
|
301134
By:
Catalina V. Stefanescu
|
11:35 AM 08/12/2002
|
|
A More Powerful Average Bioequivalence Analysis for the 2x2 Crossover
|
|
301296
By:
Dongsheng Tu
|
12:05 PM 08/13/2002
|
|
A Comparison of Some Statistical Procedures for Therapeutic Equivalence Clinical Trials with Survival Endpoints
|
|
301495
By:
Ghanshyam Gupta
|
10:35 AM 08/13/2002
|
|
A Review of Equivalence Testing in Clinical Trials
|
|
301710
By:
Richard J. McNally
|
9:05 AM 08/13/2002
|
|
Comparison of Tests for Individual and Population Bioequivalence in 3-period Crossover Designs
|
|
301955
By:
Yi Tsong
|
3:35 PM 08/11/2002
|
|
Issues in Statistical Assessment of Efficacy and Safety in Special Patient Populations
|
|
